Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) ▼ | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Biogen Inc. | 49 | 1 | 7 | 1 | €199.60 | €293.57 | 47.080% |
| Incyte Corp. | 12 | 2 | 2 | 0 | €52.24 | €78.42 | 50.119% |
| Regeneron Pharmaceuticals Inc. | 36 | 1 | 3 | 0 | €892.00 | €958.32 | 7.435% |
| Elanco Animal Health Inc. | 7 | 3 | 1 | 0 | €15.48 | €15.58 | 0.653% |
| Amgen Inc. | 25 | 0 | 4 | 0 | €275.55 | €297.31 | 7.898% |
| AbbVie Inc. | 22 | 0 | 4 | 0 | €142.50 | €175.11 | 22.885% |
| Sarepta Therapeutics | 1 | 0 | 0 | 0 | €102.95 | €130.00 | 26.275% |
| Eli Lilly Corp. | 49 | 0 | 6 | 0 | €741.50 | €786.51 | 6.069% |
| Merck & Co. Inc. | 28 | 1 | 0 | 0 | €116.00 | €124.92 | 7.692% |
| Abbott Laboratories | 17 | 0 | 1 | 0 | €93.97 | €116.71 | 24.202% |
| Vertex Pharmaceuticals Inc. | 47 | 2 | 7 | 0 | €412.10 | €425.79 | 3.321% |
| Pfizer Inc. | 27 | 4 | 1 | 0 | €26.00 | €40.66 | 56.413% |
| Zoetis Inc. A | 23 | 1 | 3 | 0 | €156.82 | €200.06 | 27.571% |